MDT
Medtronic plc
—
79.34 $
+1.2000 (%+1.54)
Previous Close: 78.14
Day Low₺78.45
Day High₺79.5
MDT: Medtronic plc Financials
MDT Income Statement
Total revenue
Net income
Gross margin TTM
65.02%
Operating margin TTM
17.78%
Net profit margin TTM
13.2%
Return on investment TTM
—
| Period end | 24/04/2026 | 30/04/2025 | 30/04/2024 | 30/04/2023 |
|---|---|---|---|---|
| Total revenue | 36,364,000,000 | 33,537,000,000 | 32,364,000,000 | 31,227,000,000 |
| Operating income | 6,467,000,000 | 5,955,000,000 | 5,144,000,000 | 5,485,000,000 |
| Net income | 4,800,000,000 | 4,662,000,000 | 3,676,000,000 | 3,758,000,000 |
All line items
| Line item | 24/04/2026 | 30/04/2025 | 30/04/2024 | 30/04/2023 |
|---|---|---|---|---|
| Total revenue | 36,364,000,000 | 33,537,000,000 | 32,364,000,000 | 31,227,000,000 |
| Cost of revenue | 12,721,000,000 | 11,632,000,000 | 11,216,000,000 | 10,719,000,000 |
| Gross profit | 23,643,000,000 | 21,905,000,000 | 21,148,000,000 | 20,508,000,000 |
| Research and development expenses | 2,873,000,000 | 2,732,000,000 | 2,735,000,000 | 2,696,000,000 |
| General and administrative expenses | 0 | 0 | 0 | 0 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 11,784,000,000 | 10,849,000,000 | 10,736,000,000 | 10,415,000,000 |
| Other expenses | 2,520,000,000 | 2,369,000,000 | 2,533,000,000 | 1,912,000,000 |
| Operating expenses | 17,179,000,000 | 15,950,000,000 | 16,004,000,000 | 15,023,000,000 |
| Cost and expenses | 29,900,000,000 | 27,582,000,000 | 27,220,000,000 | 25,742,000,000 |
| Net interest income | -715,000,000 | -729,000,000 | -719,000,000 | -636,000,000 |
| Interest income | 0 | 0 | 0 | 0 |
| Interest expense | 715,000,000 | 729,000,000 | 719,000,000 | 636,000,000 |
| Depreciation and amortization | 2,958,000,000 | 2,861,000,000 | 2,647,000,000 | 2,697,000,000 |
| EBITDA | 9,809,000,000 | 9,218,000,000 | 8,203,000,000 | 8,697,000,000 |
| EBIT | 6,851,000,000 | 6,357,000,000 | 5,556,000,000 | 6,000,000,000 |
| Non-operating income (excl. interest) | -384,000,000 | -402,000,000 | -412,000,000 | -515,000,000 |
| Operating income | 6,467,000,000 | 5,955,000,000 | 5,144,000,000 | 5,485,000,000 |
| Total other income/expenses (net) | -331,000,000 | -327,000,000 | -307,000,000 | -121,000,000 |
| Income before tax | 6,136,000,000 | 5,628,000,000 | 4,837,000,000 | 5,364,000,000 |
| Income tax expense | 1,299,000,000 | 936,000,000 | 1,133,000,000 | 1,580,000,000 |
| Net income from continuing operations | 4,837,000,000 | 4,691,000,000 | 3,704,000,000 | 3,784,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | -1,000,000 | 0 |
| Net income | 4,800,000,000 | 4,662,000,000 | 3,676,000,000 | 3,758,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 4,800,000,000 | 4,662,000,000 | 3,676,000,000 | 3,758,000,000 |
| EPS | 4 | 4 | 3 | 3 |
| Diluted EPS | 4 | 4 | 3 | 3 |
| Weighted average shares outstanding | 1,281,800,000 | 1,285,600,000 | 1,327,700,000 | 1,329,800,000 |
| Weighted average diluted shares outstanding | 1,288,100,000 | 1,289,900,000 | 1,330,200,000 | 1,332,800,000 |